• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度视网膜母细胞瘤患儿被遗弃的原因、后果和预防。

Causes, outcome and prevention of abandonment in retinoblastoma in India.

机构信息

Division of Paediatric Haematology-Oncology, Department of Paediatrics, King George's Medical University Lucknow, Uttar Pradesh, India.

出版信息

Pediatr Blood Cancer. 2013 May;60(5):771-5. doi: 10.1002/pbc.24454. Epub 2013 Jan 9.

DOI:10.1002/pbc.24454
PMID:23303533
Abstract

BACKGROUND

The high-cure rates of 90% in retinoblastoma are not replicated in developing countries due to late presentation and poor compliance to treatment. The present study takes a closer look at causes of abandonment of therapy and effectiveness of counselling in reducing abandonment.

PROCEDURE

A retrospective study of children with retinoblastoma registered at our centre from March 2008 through August 2011.

RESULTS

Fifty (49.50%) of 101 children registered for treatment abandoned therapy. Abandonment rates were significantly higher in rural as compared to urban children (P = 0.02). There was no significant difference in rate of abandonment between stages or laterality of disease and other socio-demographic factors. Telephone calls were more effective than letters in tracing patients (31.2% vs. 2.4%). Major reasons cited behind abandonment were financial problems (30%) and unwillingness to enucleate (20%). Of the 12 children who returned and were retreated 6 (50%) died of progressive disease. Nineteen (73%) of those who did not return died at home. Abandonment rates steadily declined from 71.42% in 2008 to 16.66% in 2011 (P = 0.01) due to effective pre-abandonment counselling by a support team under the National Retinoblastoma Registry of India from 2009.

CONCLUSIONS

Abandonment rates for children with retinoblastoma continue to be unacceptably high. Rural background, financial constraints and hesitancy to enucleate were important causes behind abandonment. Outcome of patients who abandoned treatment was uniformly dismal. Inclusion of support team and intensified initial counselling helped in improving compliance.

摘要

背景

由于就诊较晚和治疗依从性差,发展中国家的视网膜母细胞瘤治愈率高达 90%,这一数字无法得到复制。本研究更深入地探讨了放弃治疗的原因,并研究了咨询在减少放弃治疗方面的效果。

方法

对 2008 年 3 月至 2011 年 8 月在我们中心登记的患有视网膜母细胞瘤的儿童进行回顾性研究。

结果

登记接受治疗的 101 名儿童中,有 50 名(49.5%)放弃了治疗。与城市儿童相比,农村儿童的放弃率明显更高(P=0.02)。疾病的分期、侧别和其他社会人口因素与放弃率无显著差异。电话追踪比信件更有效(31.2%对 2.4%)。放弃治疗的主要原因是经济问题(30%)和不愿眼球摘除(20%)。12 名返回并接受再治疗的儿童中,有 6 名(50%)因疾病进展而死亡。未返回的 19 名儿童中有 19 名(73%)在家中死亡。由于印度国家视网膜母细胞瘤登记处的支持小组从 2009 年开始进行有效的预放弃咨询,放弃率从 2008 年的 71.42%稳步下降至 2011 年的 16.66%(P=0.01)。

结论

患有视网膜母细胞瘤的儿童的放弃率仍然高得令人无法接受。农村背景、经济限制和不愿眼球摘除是放弃治疗的重要原因。放弃治疗的患者的预后普遍较差。纳入支持小组和强化初始咨询有助于提高依从性。

相似文献

1
Causes, outcome and prevention of abandonment in retinoblastoma in India.印度视网膜母细胞瘤患儿被遗弃的原因、后果和预防。
Pediatr Blood Cancer. 2013 May;60(5):771-5. doi: 10.1002/pbc.24454. Epub 2013 Jan 9.
2
Prevalence, predictors, causes of treatment refusal and abandonment in children with acute lymphoblastic leukaemia over 18 years in North India. Treatment phase affecting factors: A step towards better focussed counselling.印度北部 18 岁以上急性淋巴细胞白血病儿童的患病率、预测因素、治疗拒绝和放弃的原因。治疗阶段影响因素:更好地有针对性咨询的一步。
Cancer Epidemiol. 2018 Dec;57:53-59. doi: 10.1016/j.canep.2018.07.011. Epub 2018 Oct 11.
3
Treatment refusal and abandonment in childhood acute lymphoblastic leukemia in Indonesia: an analysis of causes and consequences.印度尼西亚儿童急性淋巴细胞白血病治疗拒绝和放弃:原因和后果分析。
Psychooncology. 2010 Apr;19(4):361-7. doi: 10.1002/pon.1578.
4
The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common.在治疗延误情况常见的背景下,视网膜母细胞瘤患者拒绝遵循医嘱治疗的影响。
Ophthalmic Genet. 2009 Mar;30(1):31-6. doi: 10.1080/13816810802464320.
5
Strategies to manage retinoblastoma in developing countries.发展中国家视网膜母细胞瘤的管理策略。
Pediatr Blood Cancer. 2011 Mar;56(3):341-8. doi: 10.1002/pbc.22843. Epub 2010 Nov 11.
6
Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.伊朗的视网膜母细胞瘤:患者生存率和眼球生存率方面的结果
Br J Ophthalmol. 2009 Jan;93(1):28-32. doi: 10.1136/bjo.2008.139410. Epub 2008 Oct 24.
7
SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries.SIOP-PODC 关于发展中国家视网膜母细胞瘤分级强度治疗的建议。
Pediatr Blood Cancer. 2013 May;60(5):719-27. doi: 10.1002/pbc.24468. Epub 2013 Jan 17.
8
Retinoblastoma in Central America: report from the Central American Association of Pediatric Hematology Oncology (AHOPCA).中美洲视网膜母细胞瘤:来自中美洲儿科血液学和肿瘤学协会 (AHOPCA) 的报告。
Pediatr Blood Cancer. 2012 Apr;58(4):545-50. doi: 10.1002/pbc.23307. Epub 2011 Sep 9.
9
Impact of an education program on late diagnosis of retinoblastoma in Honduras.一项教育计划对洪都拉斯视网膜母细胞瘤晚期诊断的影响。
Pediatr Blood Cancer. 2007 Nov;49(6):817-9. doi: 10.1002/pbc.21052.
10
Clinical and epidemiological characteristics of retinoblastoma: correlation with prognosis in a Turkish pediatric oncology center.视网膜母细胞瘤的临床与流行病学特征:土耳其一家儿科肿瘤中心的预后相关性
Pediatr Hematol Oncol. 2007 Apr-May;24(3):221-31. doi: 10.1080/08880010601107623.

引用本文的文献

1
Survival outcomes and globe salvage rates of retinoblastoma in India - A systematic review.印度视网膜母细胞瘤的生存结果和眼球挽救率——一项系统评价
Indian J Ophthalmol. 2025 Aug 1;73(8):1116-1123. doi: 10.4103/IJO.IJO_3033_24. Epub 2025 Jul 28.
2
Stakeholder's Perspectives on the Barriers and Facilitators of Childhood Cancer Care in India.利益相关者对印度儿童癌症护理的障碍与促进因素的看法。
Indian Pediatr. 2025 Jun 2. doi: 10.1007/s13312-025-00098-2.
3
A prospective registry study of the epidemiology and management of childhood cancer in the Gambia-The first year experience.
冈比亚儿童癌症流行病学与管理的前瞻性登记研究——第一年经验
Health Sci Rep. 2024 Sep 23;7(9):e70084. doi: 10.1002/hsr2.70084. eCollection 2024 Sep.
4
Antitumoral Potential of the Histone Demethylase Inhibitor GSK-J4 in Retinoblastoma.组蛋白去甲基化酶抑制剂 GSK-J4 在视网膜母细胞瘤中的抗肿瘤潜力。
Invest Ophthalmol Vis Sci. 2024 Feb 1;65(2):34. doi: 10.1167/iovs.65.2.34.
5
Treatment adherence in retinoblastoma: A retro-prospective cohort study in Ivory Coast and the Democratic Republic of Congo.视网膜母细胞瘤的治疗依从性:在科特迪瓦和刚果民主共和国进行的一项回顾性队列研究。
Cancer Rep (Hoboken). 2023 Dec 26;7(2):e1949. doi: 10.1002/cnr2.1949.
6
Determinants of delayed childhood cancer care in low- and middle-income countries: A systematic review.中低收入国家儿童癌症治疗延误的决定因素:系统评价。
Pediatr Blood Cancer. 2023 Mar;70(3):e30175. doi: 10.1002/pbc.30175. Epub 2022 Dec 29.
7
Risk factors associated with abandonment of care in retinoblastoma: analysis of 692 patients from 10 countries.与视网膜母细胞瘤放弃治疗相关的风险因素:来自 10 个国家的 692 例患者分析。
Br J Ophthalmol. 2023 Nov 22;107(12):1818-1822. doi: 10.1136/bjo-2022-321159.
8
Natural History of Untreated Retinoblastoma.未经治疗的视网膜母细胞瘤的自然病史。
Cancers (Basel). 2021 Jul 21;13(15):3646. doi: 10.3390/cancers13153646.
9
Treatment Outcome of Children with Retinoblastoma in a Tertiary Care Referral Hospital in Indonesia.印度尼西亚一家三级转诊医院治疗视网膜母细胞瘤患儿的结果。
Asian Pac J Cancer Prev. 2021 May 1;22(5):1613-1621. doi: 10.31557/APJCP.2021.22.5.1613.
10
Patient tracking during treatment of children with cancer in India - An exploratory study.印度癌症患儿治疗期间的患者跟踪:一项探索性研究。
Cancer Rep (Hoboken). 2022 Jun;5(6):e1359. doi: 10.1002/cnr2.1359. Epub 2021 Feb 23.